Freenome Establishes Interim Office of the CEO With Riley Ennis, Co Founder, Taking Lead Role
09/25/24, 6:23 PM
Location
san franciscoIndustry
biotechnology
Mike Nolan has resigned as chief executive officer (CEO) of Freenome for personal reasons. The Board of Directors has established an interim Office of the CEO, led by Freenome's co-founder Riley Ennis, with assistance from Douglas VanOort, a Freenome Board member and former chairman of the board and CEO at NeoGenomics, to provide leadership continuity and operational management during the transition. The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood-based screening to patients.
Company Info
Location
san francisco, california, united states
Additional Info
Freenome is breaking barriers to early cancer detection with a suite of blood tests built on its multiomics platform. The company recognizes that no single technology can identify every cancer due to the disease's inherent heterogeneity. Freenome's multimodal approach combines molecular biology and assays with computational biology, machine learning and multiple data types to tune into cancer's subtlest cues, even at the earliest stages of the disease.